Longitudinal Analysis of Pulmonary Function Impairment One Year Post-COVID-19: A Single-Center Study
暂无分享,去创建一个
M. Marc | D. Manolescu | O. Fira-Mladinescu | Daniel Traila | Cristian-Iulian Oancea | A. Motofelea | Emanuela Vaștag | N. Suppini | Ram Kiran Maganti
[1] D. J. Mehagnoul-Schipper,et al. Pulmonary function three to five months after hospital discharge for COVID-19: a single centre cohort study , 2023, Scientific Reports.
[2] Zhen-xiong Zheng,et al. Pulmonary fibrosis: A short- or long-term sequelae of severe COVID-19? , 2023, Chinese Medical Journal Pulmonary and Critical Care Medicine.
[3] M. Humbert,et al. Characteristics and outcomes of asthmatic outpatients with COVID-19 who receive home telesurveillance , 2022, ERJ Open Research.
[4] A. S. Leite,et al. Lung function six months after severe COVID-19: Does time, in fact, heal all wounds? , 2022, The Brazilian Journal of Infectious Diseases.
[5] Funda Çoşkun,et al. Characteristics and outcomes of COVID-19 patients with IPF: A multi-center retrospective study , 2022, Respiratory Medicine and Research.
[6] A. West,et al. How COVID-19 interacts with interstitial lung disease , 2022, Breathe.
[7] G. Raghu,et al. Interstitial lung disease before and after COVID-19: a double threat? , 2021, European Respiratory Journal.
[8] Y. Hadi,et al. Patients with idiopathic pulmonary fibrosis have poor clinical outcomes with COVID-19 disease: a propensity matched multicentre research network analysis , 2021, BMJ Open Respiratory Research.
[9] Zhen Wang,et al. Outcomes among patients with COVID-19 and asthma: A systematic review and meta-analysis. , 2021, Allergy and asthma proceedings.
[10] J. Sohn,et al. Interstitial lung disease increases susceptibility to and severity of COVID-19 , 2021, European Respiratory Journal.
[11] Shi-Ming Chen,et al. The characteristics and evolution of pulmonary fibrosis in COVID-19 patients as assessed by AI-assisted chest HRCT , 2021, PloS one.
[12] D. Brodie,et al. Post-acute COVID-19 syndrome , 2021, Nature Medicine.
[13] L. Ebner,et al. Pulmonary function and radiological features 4 months after COVID-19: first results from the national prospective observational Swiss COVID-19 lung study , 2021, European Respiratory Journal.
[14] Z. Daniil,et al. Early COVID-19 lockdown in Greece and idiopathic pulmonary fibrosis: a beneficial “impact” beyond any expectation , 2020, European Respiratory Journal.
[15] J. Soriano,et al. The impact of COVID-19 on patients with asthma , 2020, European Respiratory Journal.
[16] G. Abecasis,et al. Type 2 and interferon inflammation regulate SARS-CoV-2 entry factor expression in the airway epithelium , 2020, Nature Communications.
[17] Jordan J. Clark,et al. Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter Study , 2020, American journal of respiratory and critical care medicine.
[18] H. J. Kim,et al. Effect of asthma and asthma medication on the prognosis of patients with COVID-19 , 2020, European Respiratory Journal.
[19] S. El-Chemaly,et al. Increased Odds of Death for Patients with Interstitial Lung Disease and COVID-19: A Case–Control Study , 2020, American journal of respiratory and critical care medicine.
[20] G. Passalacqua,et al. Clinical course and outcomes of patients with asthma hospitalized for severe acute respiratory syndrome coronavirus 2 pneumonia , 2020, Annals of Allergy, Asthma & Immunology.
[21] M. d’Ortho,et al. Functional characteristics of patients with SARS-CoV-2 pneumonia at 30 days post-infection , 2020, European Respiratory Journal.
[22] A. Peters,et al. Prevalence and characterization of asthma in hospitalized and nonhospitalized patients with COVID-19 , 2020, Journal of Allergy and Clinical Immunology.
[23] Bin Zhang,et al. Anormal pulmonary function and residual CT abnormalities in rehabilitating COVID-19 patients after discharge , 2020, Journal of Infection.
[24] J. Stingone,et al. Asthma among hospitalized patients with COVID-19 and related outcomes , 2020, Journal of Allergy and Clinical Immunology.
[25] Hong Yang,et al. Analysis of thin-section CT in patients with coronavirus disease (COVID-19) after hospital discharge , 2020, Journal of X-ray science and technology.
[26] Xiao-Neng Mo,et al. Abnormal pulmonary function in COVID-19 patients at time of hospital discharge , 2020, European Respiratory Journal.
[27] P. Gergen,et al. Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2 , 2020, Journal of Allergy and Clinical Immunology.
[28] K. Yuen,et al. Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.
[29] Heshui Shi,et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study , 2020, The Lancet Infectious Diseases.
[30] Peixun Zhang,et al. Long-term bone and lung consequences associated with hospital-acquired severe acute respiratory syndrome: a 15-year follow-up from a prospective cohort study , 2020, Bone Research.
[31] Kevin McCarthy,et al. Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement , 2019, American journal of respiratory and critical care medicine.
[32] Edward Y Lee,et al. Follow-up chest radiographic findings in patients with MERS-CoV after recovery , 2017, Indian Journal of Radiology and Imaging.
[33] F. Nuttall,et al. Body Mass Index , 2020, Definitions.
[34] J. Hankinson,et al. Interpretative strategies for lung function tests , 2005, European Respiratory Journal.
[35] M. Leow,et al. 1-Year Pulmonary Function and Health Status in Survivors of Severe Acute Respiratory Syndrome , 2005, Chest.
[36] J. Sung,et al. Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors , 2005, Thorax.